ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 150289 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 150289; 2) Community: the network communities that were significantly associated with the response to NSC 150289; 3) Molecule: the relationships between components within communities and NSC 150289; 4) MDR: the compounds that were significantly associated with the NSC 150289.

NSC Compound Enrichment Correlation
NSC 743434 8-(4-{5-[3-(4-fluoro phenyl)-3-oxo-1-prophenyl]-2-methoxy phenoxy}pentoxy)-7-methoxy-2,3,5,11-a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a],[1,4]diazepin-5-one 0.0406225271888773 0.40299107
NSC 745455 Null 0.0406225271888773 0.52106884
NSC 748404 Null 0.0406225271888773 0.46004935
NSC 748707 Null 0.0406225271888773 0.34909403
NSC 749862 3-[2-(4-methoxyphenyl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.0406225271888773 0.15781638
NSC 750324 Null 0.0406225271888773 0.32420056
NSC 755443 Null 0.0406225271888773 0.26018895
NSC 760181 9-(3-fluorobenzyl)-7-(3-fluorobenzyloxy)-2-(4-fluorobenzyl)-1-methyl-9H-beta-carbolinium bromide 0.0406225271888773 0.31537685
NSC 9706 Triethylenemelamine 0.0406225271888773 0.30876869
NSC 107124 Camptothecin Derivative 0.0406225271888776 0.27276657
Total:162  Current:143    [First] [Prev] [Next] [Last]